EMA and European medicines regulatory network lift COVID-19 business continuity status

EMA

10 May 2023 - EMA and the European medicines regulatory network are lifting their respective COVID-19 business continuity measures after successfully handling the unprecedented operational challenges posed by the pandemic. 

This was foreseen in the EMA’s workplan for 2023-2025.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Europe , Public health , COVID-19